Road walked on:
Benjamin Breuil received his technical degree in France, in 1998. From 1999 to 2008 he worked as an assistant engineer in food security and pharmaceutical companies and acquired differents skills in analytical chemistry, robotic and transcriptomics. Recruited permanently at INSERM in 2014, Benjamin Breuil is an assistant engineer at the Renal Fibrosis Lab, INSERM U1048 since 2008.
Main domains of expertise:
Urinary biomarker, Clinical proteomics, Metabolomics, Mass spectrometry, Capillary electrophoresis
Label-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy. Lacroix C, Caubet C, Gonzalez-de-Peredo A, Breuil B, Bouyssié D, Stella A, Garrigues L, Le Gall C, Raevel A, Massoubre A, Klein J, Decramer S, Sabourdy F, Bandin F, Burlet-Schiltz O, Monsarrat B, Schanstra JP, Bascands JL. Mol Cell Proteomics. 2014. [Read]
Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV). Klein J, Lacroix C, Caubet C, Siwy J, Zürbig P, Dakna M, Muller F, Breuil B, Stalmach A, Mullen W, Mischak H, Bandin F, Monsarrat B, Bascands JL, Decramer S, Schanstra JP. Sci Transl Med. 2013. [Read]
Long term metabolic syndrome induced by a high fat high fructose diet leads to minimal renal injury in C57BL/6 mice. Dissard R, Klein J, Caubet C, Breuil B, Siwy J, Hoffman J, Sicard L, Ducassé L, Rascalou S, Payre B, Buléon M, Mullen W, Mischak H, Tack I, Bascands JL, Buffin-Meyer B, Schanstra JP. PLoS One. 2013. [Read]